Megan Rothney is a seasoned product management executive focused on developing growth strategies for diagnostics and precision medicine companies. With deep experience in both clinical practice and technical applications, Rothney is skilled at seamlessly bridging the gap between development, clinical and commercial environments. She has a strong passion for integrating actionable technology into the healthcare space.

Rothney received her Bioengineering degree at the University of Pittsburgh and her PhD in Biomedical Engineering at Vanderbilt University. She has held leadership positions at notable companies such as PathAI, Verily Life Sciences and Genomic Health, where she served as Director of Oncology Product Management. Additionally, Rothney has held positions at GE Global Research and the National Institutes of Health.

Throughout her career, Rothney has demonstrated expertise in life cycle management, market planning, product development, cross-functional team leadership, key opinion leaders, and FDA submission. Her knowledge extends to areas such as molecular diagnostics, medical imaging, health technology, oncology, cancer screening, and type II diabetes. She excels at personnel management and team building while also being able to navigate complex market access and reimbursement challenges.

Overall, Megan Rothney's adroit knowledge of the healthcare industry and product management make her an invaluable asset to any team focusing on precision medicine and diagnostics.